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Background: Transcatheter aortic valve implantation (TAVI) was proved to be a preferred method of 
severe aortic stenosis treatment in patients with medium and high surgical risk. However, that signifi-
cant superiority over surgery is maintained only if femoral approach is possible.1 Aim: We analyzed 
changes of approach to TAVI implantation before and after the introduction of percutaneous trans-
femoral implantation, together with data on 12-months survival, complications and hospital stay. 
Results: Among a total of 149 patients who received TAVI in our center, there were 94 implantations 
before and 55 implantations after the introduction of routine percutaneous implantation when it is 
feasible (with surgical cut-down reserved only for patients with peripheral artery disease). There were 
no significant differences in patients’ characteristics and risk factors among patients operated during 
two different periods. All 82 femoral procedures during the first period were performed with surgical 
cut-down, in addition to 9 transapical and 2 transaortic implantations. In the second period, there were 
54 femoral implantations (30 with surgical cut down and 24 full percutaneous) and 1 transapical im-
plantation. 12-month mortality (16% vs 7%), and median duration of hospitalization (10 vs 8 days) were 
lower among patients treated in the second period. However, there were more vascular complications 
in the second period (2% vs 9%), that were mostly resolved during the procedure, or within one day. 
Conclusions: After the introduction of full percutaneous approach to TAVI we observed a decrease in 
postoperative mortality, and reduction of hospital stay length, most probably due to significant de-
crease in relative proportion of transapical approach and routine surgical cut-down. Relative increase 
in vascular complications due to persistent selection of transfemoral approach in patients with chal-
lenging vascular access did not result in prolonged hospital stay or excess mortality. Future strategies 
for TAVI, especially during and after the pandemic era, will most probably favor fast-track approach, 
leaving hospital resources readily and longer available mainly for the most complicated patients.
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